A cataract is a clouding of the normally clear lens of your eye.
For people who have cataracts, seeing through cloudy lenses is a bit like looking through a frosty or fogged-up window.
Clouded vision caused by cataracts can make it more difficult to read, drive a car (especially at night) or see the expression on a friend’s face.
Based on some research, cataracts are the most common cause of vision loss in people over the age of 40 and also the major cause of blindness in the world.
Most cataracts develop slowly and don’t disturb your eyesight early on. But with time, cataracts will eventually interfere with your vision.
At first, stronger lighting and eyeglasses can help you deal with cataracts. But if impaired vision interferes with your usual activities, you might need cataract surgery. Fortunately, cataract surgery is generally a safe, effective procedure.
Fortunately, scientists have discovered an eye drops that can melt away cataracts.
Scientists in California have discovered that the naturally occurring steroid lanosterol is able to melt away cataracts and prevent them from returning when administered to patients via eye drops. If approved for human use, the compound would be available as a non-invasive treatment for individuals with moderate forms of cataracts.
THE STUDY
Scientists first became aware of lanosterol cataract-blocking abilities by observing two children in China who had a hereditary form of the condition. Upon closer examination, it became clear that the children shared a mutation that blocked the production of the steroid lanosterol, Science Alert reported. Their parents lacked this mutation and as a result never went on to develop cataracts. From this observation, the team proposed that the steroid must play a role in the formation of cataracts.
In a series of experiments outlined in a study now published in Nature, the team tested lanosterol on donated human lenses and live rabbits and dogs. Results repeatedly showed that lanosterol was able to significantly shrink cataract size.It is
Some studies also identifies lanosterol as a key molecule in the prevention of lens protein aggregation and points to a novel strategy for cataract prevention and treatment.
According to Tech Times, if the drops prove to also work on humans, they could offer a non-invasive treatment for individuals with mild to moderate cataracts and serve as a way to prevent the condition from ever returning.
While cataract surgery is relatively easy and safe, the drops would serve as an easier alternative for the 50 million Americans estimated to be afflicted by the condition by the year 2050.
Walang komento: